Predictors of Non-Adherence to Aromatase Inhibitors Among Commercially Insured Women with Breast Cancer - Express-Scripts.com

Research & Consumerology

Predictors of Non-Adherence to Aromatase Inhibitors
Among Commercially Insured Women with Breast Cancer

Published: May 22, 2010
By: Sedjo R, Devine ST. Breast Cancer Res Treat. 2010 May 22. [Epub ahead of print]

ST. LOUIS – Researchers from Express Scripts investigated 1-year adherence rates to aromatase inhibitors (AI) and determined risk factors for non-adherence among commercially insured post-menopausal breast cancer patients. The study found that a number of factors influence patients' non-adherence, such as out-of-pocket costs and comorbidity, and mail-order pharmacy use.

This study was published in the journal Breast Cancer Research and Treatment.



Share